Massachusetts is home to some of the world's leading medical institutions and researchers, yet many patients still struggle to access the very innovations being developed here.

Biomarker testing has become an essential part of modern cancer care. It helps doctors identify the treatments most likely to work for a particular patient, avoiding unnecessary delays and giving people the best chance at successful outcomes. As new cancer therapies continue to emerge, access to this testing is becoming increasingly important.

Unfortunately, insurance coverage has not always kept pace with advances in medicine. Massachusetts Legislation H.4339/S.809 would help close that gap by ensuring patients have access to medically appropriate biomarker testing when they need it.

I am grateful to State Representative Bill McGregor for his leadership on this issue and his commitment to keeping Massachusetts at the forefront of healthcare innovation.

If Massachusetts is going to continue leading the way in developing lifesaving treatments, we should also lead in making sure patients can benefit from them.

K Jerome

West Roxbury

Advertisement